Hong Kong: Prenetics looks for more M&A following acquisition of majority stake in ACT Genonmics

Nasdaq-listed Prenetics Global, a global diagnostic and genetic testing company, has acquired a majority stake in ACT Genomics, an Asia-based genomics company specialising in precision oncology with operations in Hong Kong, Taiwan, Japan, Singapore, Thailand and the UK. There is likely to be more transactions as the firm continues with its growth strategy. Prenetics agreed…

You must be a HMI Subscriber to view this content.

Subscribe Now »